Identification and characterization of factors involved in cyp3a4 inter-individual variability

Project Information

CRISTINA RODRIGUEZ A

Grant agreement ID: QLG5-CT-2002-51733

Project closed

Start date 1 January 2003

End date 31 December 2004

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 150 804,00

EU contribution € 150 804,00

Coordinated by

KAROLINSKA INSTITUTE
Sweden

Objective

Cytochrome P450 3A4 bio transforms many xenobiotics in human liver and has a highly variable expression. Identification of the genetic factors underling this variability is a key step in the prevention of fatal adverse drug reactions and carcinogen sis.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

• medical and health sciences › basic medicine › pharmacology and pharmacy › adverse drug reactions

You need to log in or register to use this function

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-11. - Research relating to the persons with disabilities

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

KAROLINSKA INSTITUTE

• EU contribution: No data
• Address: Nobels Vaeg, 13 ; 171 77 STOCKHOLM ; Sweden
• Total cost: No data